is semaglutide going to stop being compounded Troubling Findings in Study of GLP-1 Compounders Did the FDA Ban Compounded

Some start with a GLP-1 to see how their body responds

Lancet 371 , 651659 (2008)

In 2023, Pfizer published research papers successively, reporting the results of randomized clinical trials on the efficacy and safety of PF-06882961 for blood sugar control in patients with type 2 diabetes, the safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06882961 in Japanese adults with type 2 diabetes from a phase 1 clinical trial, and the results of a 12-week randomized, placebo-controlled, dose-escalation phase 2 trial on the tolerability, safety, and pharmacodynamics of PF-06882961 for the treatment of type 2 diabetes

Palpitations (awareness of heartbeat)

Malignant thoracic intraspinal melanotic schwannoma

It's given as a once-weekly subcutaneous injection in the thigh or abdomen, with your dose set for you and increased gradually as your body adapts